NO20065701L - Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin - Google Patents

Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Info

Publication number
NO20065701L
NO20065701L NO20065701A NO20065701A NO20065701L NO 20065701 L NO20065701 L NO 20065701L NO 20065701 A NO20065701 A NO 20065701A NO 20065701 A NO20065701 A NO 20065701A NO 20065701 L NO20065701 L NO 20065701L
Authority
NO
Norway
Prior art keywords
oromucosal
agomelatine
pharmaceutical composition
sublingual administration
orodispersible pharmaceutical
Prior art date
Application number
NO20065701A
Other languages
English (en)
Norwegian (no)
Inventor
Patrick Wuthrich
Marc Julien
Francois Tharrault
Jean-Manuel Pean
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065701(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20065701L publication Critical patent/NO20065701L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20065701A 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin NO20065701L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine

Publications (1)

Publication Number Publication Date
NO20065701L true NO20065701L (no) 2007-06-15

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065701A NO20065701L (no) 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Country Status (41)

Country Link
US (1) US7892575B2 (ko)
EP (1) EP1800669B1 (ko)
JP (2) JP4996225B2 (ko)
KR (3) KR20070063420A (ko)
CN (2) CN1981752B (ko)
AP (1) AP2714A (ko)
AR (1) AR058332A1 (ko)
AT (1) ATE474561T1 (ko)
AU (1) AU2006252051B2 (ko)
BR (1) BRPI0605214A (ko)
CA (1) CA2571202C (ko)
CO (1) CO5770094A1 (ko)
CR (1) CR8788A (ko)
CU (1) CU23603B7 (ko)
CY (1) CY1110824T1 (ko)
DE (1) DE602006015592D1 (ko)
DK (1) DK1800669T3 (ko)
EA (1) EA013751B1 (ko)
ES (1) ES2348994T3 (ko)
FR (1) FR2894475B1 (ko)
GE (1) GEP20084509B (ko)
GT (1) GT200600500A (ko)
HK (1) HK1101802A1 (ko)
HN (1) HN2008000874A (ko)
HR (1) HRP20100517T1 (ko)
IL (1) IL180036A0 (ko)
MA (1) MA28722B1 (ko)
MX (1) MXPA06014605A (ko)
MY (1) MY143221A (ko)
NO (1) NO20065701L (ko)
NZ (1) NZ552025A (ko)
PE (1) PE20071030A1 (ko)
PL (1) PL1800669T3 (ko)
PT (1) PT1800669E (ko)
RS (1) RS51452B (ko)
SG (1) SG133531A1 (ko)
SI (1) SI1800669T1 (ko)
TW (1) TWI327911B (ko)
UA (1) UA86622C2 (ko)
WO (1) WO2007068829A1 (ko)
ZA (1) ZA200610511B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
ES2422281T3 (es) 2009-04-09 2013-09-10 E Pharma Trento Spa Granulado para la formulación de comprimidos bucodispersables
CN101781226B (zh) * 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
EP2665465A1 (en) 2011-01-17 2013-11-27 Takeda Pharmaceutical Company Limited Orally dispersible tablet
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2765985A1 (en) * 2011-10-14 2014-08-20 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
HUE036989T2 (hu) 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
WO2015119641A1 (en) * 2014-02-07 2015-08-13 Scilabs Pharmaceuticals All natural, non-toxic sublingual drug delivery systems
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
EA200602104A1 (ru) 2007-06-29
GEP20084509B (en) 2008-10-10
CA2571202A1 (fr) 2007-06-14
HN2008000874A (es) 2012-02-27
HK1101802A1 (en) 2007-10-26
EA013751B1 (ru) 2010-06-30
CU20060243A7 (es) 2009-09-08
MA28722B1 (fr) 2007-07-02
AU2006252051A1 (en) 2007-06-28
EP1800669A1 (fr) 2007-06-27
PE20071030A1 (es) 2007-11-17
DK1800669T3 (da) 2010-10-25
JP4996225B2 (ja) 2012-08-08
IL180036A0 (en) 2008-01-20
KR20100012858A (ko) 2010-02-08
GT200600500A (es) 2007-07-25
TW200738230A (en) 2007-10-16
RS51452B (en) 2011-04-30
US20070134331A1 (en) 2007-06-14
SG133531A1 (en) 2007-07-30
NZ552025A (en) 2008-12-24
CO5770094A1 (es) 2007-06-29
CU23603B7 (es) 2010-12-08
AR058332A1 (es) 2008-01-30
HRP20100517T1 (hr) 2010-10-31
JP2007182440A (ja) 2007-07-19
PL1800669T3 (pl) 2010-12-31
MXPA06014605A (es) 2009-02-11
ES2348994T3 (es) 2010-12-21
SI1800669T1 (sl) 2010-11-30
CY1110824T1 (el) 2015-06-10
CR8788A (es) 2008-08-21
AU2006252051B2 (en) 2013-03-14
CN1981752A (zh) 2007-06-20
KR101013667B1 (ko) 2011-02-10
ATE474561T1 (de) 2010-08-15
DE602006015592D1 (de) 2010-09-02
CA2571202C (fr) 2012-01-10
KR20080108068A (ko) 2008-12-11
AP2006003844A0 (en) 2006-12-31
JP2012092132A (ja) 2012-05-17
FR2894475B1 (fr) 2008-05-16
UA86622C2 (ru) 2009-05-12
TWI327911B (en) 2010-08-01
CN101919800A (zh) 2010-12-22
AP2714A (en) 2013-07-31
US7892575B2 (en) 2011-02-22
PT1800669E (pt) 2010-08-17
MY143221A (en) 2011-03-31
ZA200610511B (en) 2008-05-28
FR2894475A1 (fr) 2007-06-15
CN1981752B (zh) 2011-11-02
WO2007068829A1 (fr) 2007-06-21
BRPI0605214A (pt) 2007-10-09
EP1800669B1 (fr) 2010-07-21
KR20070063420A (ko) 2007-06-19

Similar Documents

Publication Publication Date Title
NO20065701L (no) Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
TW200621313A (en) Pharmaceutical compositions
EA200802444A1 (ru) Стабилизированные фармацевтические композиции, содержащие фезотеродин
NO20043367L (no) Oralt farmasoytisk preparat
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
NO20080991L (no) Bazedoksifen acetat formuleringer
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
DK1971216T4 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
ECSP088574A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
BRPI0820659A2 (pt) composto, prodroga de composto, composição farmacêutica e formulação oral e uso de composto.
ITMI20041664A1 (it) Composizione, particolarmente per la preparazione di malte cementizie.
CL2008003918A1 (es) Compuesto derivado de gama-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, dispositivo intrauterino que lo contiene y su uso para la contracepcion oral y para trastornos pre, peri y postmenopausicos.
TNSN06396A1 (fr) Compositions pharmaceutiques orodispersible pour administration oromucosale ou sublinguale d'agomelatine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application